DK0574048T3 - Peptider og nucleinsyresekvenser relateret til Epstein-Barr-virus - Google Patents

Peptider og nucleinsyresekvenser relateret til Epstein-Barr-virus

Info

Publication number
DK0574048T3
DK0574048T3 DK93200691T DK93200691T DK0574048T3 DK 0574048 T3 DK0574048 T3 DK 0574048T3 DK 93200691 T DK93200691 T DK 93200691T DK 93200691 T DK93200691 T DK 93200691T DK 0574048 T3 DK0574048 T3 DK 0574048T3
Authority
DK
Denmark
Prior art keywords
peptides
nucleic acid
ebv
epstein
antibodies
Prior art date
Application number
DK93200691T
Other languages
English (en)
Inventor
J M Middeldorp
Original Assignee
Organon Teknika Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Teknika Bv filed Critical Organon Teknika Bv
Application granted granted Critical
Publication of DK0574048T3 publication Critical patent/DK0574048T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DK93200691T 1992-03-13 1993-03-10 Peptider og nucleinsyresekvenser relateret til Epstein-Barr-virus DK0574048T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200721 1992-03-13

Publications (1)

Publication Number Publication Date
DK0574048T3 true DK0574048T3 (da) 2002-12-16

Family

ID=8210477

Family Applications (2)

Application Number Title Priority Date Filing Date
DK93200691T DK0574048T3 (da) 1992-03-13 1993-03-10 Peptider og nucleinsyresekvenser relateret til Epstein-Barr-virus
DK02075193T DK1225226T3 (da) 1992-03-13 1993-03-10 Peptider og nucleinsyresekvenser beslægtet med Epstein-Barr-virus

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK02075193T DK1225226T3 (da) 1992-03-13 1993-03-10 Peptider og nucleinsyresekvenser beslægtet med Epstein-Barr-virus

Country Status (13)

Country Link
US (1) US5424398A (da)
EP (2) EP1225226B1 (da)
JP (3) JP4135996B2 (da)
KR (1) KR100291247B1 (da)
AT (2) ATE222291T1 (da)
AU (1) AU666920B2 (da)
CA (1) CA2092680C (da)
DE (2) DE69332197T2 (da)
DK (2) DK0574048T3 (da)
ES (2) ES2184735T3 (da)
FI (1) FI114802B (da)
PT (1) PT574048E (da)
ZA (1) ZA931797B (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE207120T1 (de) * 1993-07-23 2001-11-15 Hans Prof Dr Wolf Dna-sequenzen des epstein-barr virus kodierend für ein diagnostisch relevantes virus-hüllprotein,durch pcr erhaltene expressionsklone und verwendung dieses rekombinanten antigens in diagnostischen tests
ATE231556T1 (de) * 1993-09-14 2003-02-15 Biomerieux Bv Diagnostische reagenzien zum nachweis von antikörper gegen ebv
US5834747A (en) 1994-11-04 1998-11-10 Pixel Instruments Universal credit card apparatus and method
DE19526384C2 (de) * 1995-07-19 1997-07-10 Biotest Ag Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, sowie diese enthaltende Testkits zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern
US5813500A (en) * 1996-03-25 1998-09-29 Tenneco Automotive Inc. Anti-swish mechanism for a damper
FR2765688B1 (fr) 1997-07-04 1999-09-10 Pasteur Institut Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications
US7105496B2 (en) * 1998-07-23 2006-09-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US6797691B1 (en) 1997-07-23 2004-09-28 Northwestern University Methods and compositions for inhibiting angiogenesis
EP1627886A1 (en) * 1997-10-07 2006-02-22 Ono Pharmaceutical Co., Ltd. Polypeptide, cDNA encoding the same, and use of them
JP4472171B2 (ja) 1998-03-04 2010-06-02 アクゾ・ノベル・エヌ・ベー エプスタイン−バーウイルス（ｅｂｖ）核酸の増幅と検出のためのオリゴヌクレオチド
US20030064917A1 (en) * 1998-07-23 2003-04-03 Crawford Susan E. Methods and compositions for inhibiting angiogenesis
US6159950A (en) * 1998-10-16 2000-12-12 Cornell Research Foundation, Inc. Method of modulating hair growth
AU3988401A (en) * 2000-02-25 2001-09-03 Ludwig Inst Cancer Res Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins
US20030143647A1 (en) * 2001-09-24 2003-07-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Anticancer vaccine and diagnostic methods and reagents
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
CA2481304A1 (en) * 2002-03-27 2003-10-09 Patrick Hwu Method for treating cancer in humans
US7507568B2 (en) * 2002-09-25 2009-03-24 The Proctor & Gamble Company Three dimensional coordinates of HPTPbeta
US7226755B1 (en) * 2002-09-25 2007-06-05 The Procter & Gamble Company HPTPbeta as a target in treatment of angiogenesis mediated disorders
US6886670B2 (en) * 2003-09-29 2005-05-03 Tenneco Automotive Operating Company Inc. Extra support land for valve disc
DE10307517A1 (de) * 2003-02-21 2004-09-02 Mikrogen Molekularbiologische Entwicklungs-Gmbh Von Kapsidantigenen des Epstein-Barr-Virus abgeleitete Peptide und ihre Verwendung
US6899207B2 (en) 2003-09-29 2005-05-31 Tenneco Automotive Operating Company Inc. Extra support area for valve disc
AU2005255019B2 (en) * 2004-06-12 2011-05-19 Oregon Health And Science University Compositions and methods for diagnosis and treatment of orthopoxviruses
US7278987B2 (en) * 2004-07-09 2007-10-09 Anthony Solazzo Ergonomic urological catheterization/irrigation tray
WO2007044033A2 (en) 2004-12-07 2007-04-19 University Of Pittsburgh Of The Commonwealth System Of Higher Education Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen
EP2311531A1 (en) 2005-12-01 2011-04-20 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Anti-viral griffithsin compounds, compositions, and methods of use
CN102408470A (zh) 2005-12-23 2012-04-11 洛桑大学 用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
US7868228B2 (en) 2006-01-31 2011-01-11 Monsanto Technology Llc Phosphopantetheinyl transferases from bacteria
ES2828739T3 (es) 2006-04-07 2021-05-27 Aerpio Pharmaceuticals Inc Anticuerpos que se unen a la proteína tirosina fosfatasa beta humana (HPTP-beta) y sus usos
US8846685B2 (en) 2006-06-27 2014-09-30 Aerpio Therapeutics Inc. Human protein tyrosine phosphatase inhibitors and methods of use
US7622593B2 (en) * 2006-06-27 2009-11-24 The Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
US7589212B2 (en) * 2006-06-27 2009-09-15 Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
US7795444B2 (en) 2006-06-27 2010-09-14 Warner Chilcott Company Human protein tyrosine phosphatase inhibitors and methods of use
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
WO2009158432A2 (en) 2008-06-27 2009-12-30 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
WO2010011994A2 (en) 2008-07-25 2010-01-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Polypeptides and uses thereof
CA2737595C (en) 2008-10-14 2017-09-12 Monsanto Technology Llc Utilization of fatty acid desaturases from hemiselmis spp.
US9096555B2 (en) 2009-01-12 2015-08-04 Aerpio Therapeutics, Inc. Methods for treating vascular leak syndrome
BRPI1006897A2 (pt) 2009-07-06 2015-09-08 Akebia Therapeutics Inc compostos, composições e métodos de prevenção da metástase de células cancerosas.
US8883832B2 (en) 2009-07-06 2014-11-11 Aerpio Therapeutics Inc. Compounds, compositions, and methods for preventing metastasis of cancer cells
WO2012009705A1 (en) 2010-07-15 2012-01-19 Zyngenia, Inc. Ang-2 binding complexes and uses thereof
US20140088019A1 (en) 2011-02-11 2014-03-27 Zyngenia, Inc. Monovalent and Multivalent Multispecific Complexes and Uses Thereof
DK2714738T3 (da) 2011-05-24 2019-01-28 Zyngenia Inc Multivalente og monovalente multispecifikke komplekser og deres anvendelser
WO2013025479A1 (en) 2011-08-16 2013-02-21 Emory University Jaml specific binding agents, antibodies, and uses related thereto
MX363351B (es) 2011-10-13 2019-03-20 Aerpio Therapeutics Inc Un agente de unión a hptp?-ecd para usarse en el tratamiento de síndrome de fuga vascular.
MX2015013163A (es) 2013-03-15 2016-04-04 Zyngenia Inc Complejos multiespecificos multivalente y monovalentes y sus usos.
EP2813849A1 (en) * 2013-06-10 2014-12-17 Charité-Universitätsmedizin Berlin (Charité) EBV-specific immune signature as diagnostic markers in Chronic Fatigue Syndrome (CFS)
US11034736B2 (en) 2014-01-09 2021-06-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-viral cnidarins
WO2016130628A1 (en) 2015-02-10 2016-08-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Griffithsin mutants
WO2016130899A1 (en) 2015-02-13 2016-08-18 The Board Of Trustees Of The University Of Illinois Peptide inhibition of ccr3-mediated diseases or conditions
KR20180034390A (ko) 2015-06-15 2018-04-04 모나쉬 유니버시티 Il-37 변이체
US10703786B2 (en) 2015-10-30 2020-07-07 The University Of Melbourne Methods and compositions for improving glucose metabolism
SG11201901393VA (en) 2016-09-02 2019-03-28 Univ Illinois Kif13b-derived peptide and method of inhibiting angiogenesis
CN108490177B (zh) * 2018-02-08 2020-12-29 深圳市新产业生物医学工程股份有限公司 鼻咽癌抗体检测试剂、其制备方法及鼻咽癌检测试剂盒
WO2021021774A1 (en) 2019-07-29 2021-02-04 The Board Of Trustees Of The University Of Illinois Composition and method for promoting wound healing
US12497434B2 (en) 2019-12-20 2025-12-16 Hoffmann-La Roche Inc. IL-37 fusion proteins and uses thereof
CA3199368A1 (en) 2020-11-18 2022-05-27 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tyrosyl-lock peptides
AU2023241819A1 (en) 2022-04-01 2024-11-07 The Board Of Trustees Of The University Of Illinois Notch1 and notch4 decoys and methods of use
CN115684584B (zh) * 2022-11-01 2026-04-21 郑州安图生物工程股份有限公司 Eb病毒磁微粒化学发光检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45285T1 (de) * 1983-11-07 1989-08-15 Wistar Inst Durch antiidiotype antikoerper induzierte immune antwort zu tumoren und viren.
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
IE873041L (en) * 1987-11-11 1989-05-11 Ailbe Brennan Viral antigens, diagnostic assay therefor and vaccines¹containing them
AU6164890A (en) * 1989-08-10 1991-03-11 Northwestern University Method of identifying herpesviruses and oligonucleotides for use therein
EP0585216A1 (en) * 1989-11-24 1994-03-09 The Council Of The Queensland Institue Of Medical Research Im peptides
MX9203409A (es) * 1989-12-20 1992-07-01 Schering Corp Proteinas bcrfi como inhibidores de la gama interferona.
JPH04310861A (ja) * 1991-04-09 1992-11-02 Kazuo Yanagi 抗ｅｂｎａ抗体の測定方法および抗ｅｂｎａ抗体測定キット

Also Published As

Publication number Publication date
JP4106041B2 (ja) 2008-06-25
PT574048E (pt) 2002-12-31
ES2184735T3 (es) 2003-04-16
ES2298325T3 (es) 2008-05-16
EP1225226B1 (en) 2007-12-05
ZA931797B (en) 1993-09-30
FI931109L (fi) 1993-09-14
AU3515293A (en) 1993-09-16
JP4365440B2 (ja) 2009-11-18
DE69332197D1 (de) 2002-09-19
JP2008261851A (ja) 2008-10-30
CA2092680A1 (en) 1993-09-14
ATE222291T1 (de) 2002-08-15
EP0574048A3 (da) 1994-03-02
FI931109A0 (fi) 1993-03-12
EP0574048B1 (en) 2002-08-14
KR930019829A (ko) 1993-10-19
EP0574048A2 (en) 1993-12-15
KR100291247B1 (ko) 2001-06-01
JP4135996B2 (ja) 2008-08-20
JPH0690787A (ja) 1994-04-05
CA2092680C (en) 2006-08-08
DK1225226T3 (da) 2008-04-14
AU666920B2 (en) 1996-02-29
FI114802B (fi) 2004-12-31
DE69334191D1 (de) 2008-01-17
JP2004261183A (ja) 2004-09-24
DE69332197T2 (de) 2003-04-17
DE69334191T2 (de) 2008-11-27
EP1225226A1 (en) 2002-07-24
ATE380243T1 (de) 2007-12-15
US5424398A (en) 1995-06-13

Similar Documents

Publication Publication Date Title
DK1225226T3 (da) Peptider og nucleinsyresekvenser beslægtet med Epstein-Barr-virus
DK61595A (da) Rekombinant DNA-molekyler, værtscelletransformering dermed, værtsceller indeholdende disse samt fremgangsmåde til fremstilling af et polypeptid af IFN-alfa-typen
EP0484787A3 (en) Hcv-specific peptides, process for obtaining them and their use
HU9303703D0 (en) Hepatitis c virus (hcv) polypeptides
EP0460076A4 (en) Genetically engineered immunoglobulins
EP0151079A3 (en) Vaccine against epstein-barr virus
AU571128B2 (en) Expression of immunologically reactive aids viral protein
CA2057052A1 (en) Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
DK1253201T3 (da) Kyllingeanæmivirusmutanter og vacciner baseret på det virale protein VP3 eller sekvenser af dette virus kodende derfor
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
JPS6420095A (en) Polypeptide having anti-blood coagulating action
WO1995032292A3 (en) Detection of viral antigens coded by reverse-reading frames
PT733643E (pt) Polipeptido proteico membranar possuindo funcao de suporte do crescimento de pre-celulas b e gene para este
DK326289D0 (da) Fremgangsmaade til fremstilling af et protein ud fra gaersvampe under anvendelse af et inducerbart system, samt vektorer og transformerede stammer til brug ved fremgangsmaaden
DK35891D0 (da) Praktisk taget rent, antigenisk peptid eller protein med en epitop af haemophilus influenzae, dets fremstilling og anvendelse
RU94045154A (ru) Полипептиды, их фрагменты и варианты, препарат, днк вектор, клетка, способ продукции полипептида, вакцины, способы защиты, антитело и его фрагмент, их применение, применение днк, способ идентификации антигена
Middeldorp et al. Peptides and nucleic acid sequences related to the Epstein Barr virus
EP0754755A3 (de) Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern
IE922548A1 (en) Non-a, non-b peptide
NO910479D0 (no) Syntetiske polypeptider og antistoffer relatert til epstein-barr-virus-kjerneantigen.
Greenham et al. Application of potassium thiocyanate as a destaining agent for confirming the specificity of viral immunofluorescence
RU98119633A (ru) Способ получения полипептида, обладающего антигенной активностью вируса гепатита е. набор для определения антител к возбудителю гепатита е - вирусу гепатита е